Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Samsung Estimates 2012 CapEx At KRW25 Trillion - Quick Facts

Samsung Electronics Co. Ltd. (SSNLF.PK, SSNNF.PK) Friday revealed its estimate of 2012 capital expenditure at 25 trillion won. The company expects that the Semiconductors business would see capital expenses of 15.0 trillion won, with capital expenses for the Display Panels, or DP, segment anticipated at 6.6 trillion won. In its fourth-quarter and fiscal 2011 earnings release earlier on Friday, Samsung noted that 2011 capital expenditure amounted to 23 trillion won, of which 5.9 trillion won were incurred in the fourth-quarter. The Semiconductors business saw an investment of 13 trillion won, while 6.4 trillion won were spent on the DP segment.

Click here to receive FREE breaking news email alerts for Samsung Electronics Co. Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.